Skip to content
Oxcia

Oxcia

  • About us
    • About us
    • Management
    • Board
    • Scientific Advisory Board
    • Collaborators
    • Partnerships
    • History
    • Careers
  • Scientific Platform
    • Scientific Platform
    • Glossary
  • Pipeline
    • Pipeline
    • OXC-101
    • OXC-201
  • Investors
    • Investors
    • Governance
    • Ownership structure
    • Financial reports
    • Presentations
    • Upcoming events
    • Investor contact
  • Investerare
    • Investerare
    • Bolagsstyrning
    • Bolagsstämma
    • Ägarstruktur
    • Finansiella rapporter
    • Pressmeddelanden
    • Presentationer
    • Kalender
    • Investerarkontakt
  • News and Press
  • Contact
  • Search

Home › News and Press › Page 4

News and Press releases

View all News Press releases

Attended DDR Inhibitors Summit in Boston

February 6, 2023 · News and Press
Read article

World Cancer Day

February 4, 2023 · News and Press
Read article

New article enforces the cancer cell selective killing of OXC-101

January 25, 2023 · News and Press
Read article

Oxcia attends DDR Inhibitors Summit in Boston

January 17, 2023 · News and Press
Read article

Data show OXC-201 may be a promising treatment for allergic asthma.

October 21, 2022 · News and Press
Read article

Enrolment completed and recommended phase II dose reached for OXC-101

October 14, 2022 · News and Press
Read article

IPF awareness month

September 14, 2022 · News and Press
Read article

Oxcia welcomes Senior Scientist Sandra Ekstedt

September 9, 2022 · News and Press
Read article

LSX Nordic Congress

September 8, 2022 · News and Press
Read article

Oxcia AB is strengthening the organization further

September 6, 2022 · News and Press
Read article

Translational Director strengthens Oxcia’s team

September 2, 2022 · News and Press
Read article

Oxcia is at the LSX Nordic congress 6-7th of September 

· News and Press
Read article
« Back 1 2 3 4 5 6 Forward »

Contact us

Oxcia AB
Norrbackagatan 70C
113 34 Stockholm, Sweden

+46 (0)73 270 96 05

info@oxcia.com

Privacy policy

Menu

  • About us
    • About us
    • Management
    • Board
    • Scientific Advisory Board
    • Collaborators
    • Partnerships
    • History
    • Careers
  • Scientific Platform
    • Scientific Platform
    • Glossary
  • Pipeline
    • Pipeline
    • OXC-101
    • OXC-201
  • Investors
    • Investors
    • Governance
    • Ownership structure
    • Financial reports
    • Presentations
    • Upcoming events
    • Investor contact
  • Investerare
    • Investerare
    • Bolagsstyrning
    • Bolagsstämma
    • Ägarstruktur
    • Finansiella rapporter
    • Pressmeddelanden
    • Presentationer
    • Kalender
    • Investerarkontakt
  • News and Press
  • Contact
  • Search

Social media

  • Linkedin

OXC-201

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Innovation Council. Neither the European Union nor the European Innovation Council can be held responsible for them.


an EIC project aiming to bring hope to IPF patients

© Copyright Oxcia 2025 · Legal Notice · Information About Cookies

Search

More results

Generic filters